Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 21, Issue 7, Pages 965
Publisher
MDPI AG
Online
2016-07-22
DOI
10.3390/molecules21070965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells
- (2016) LIANG XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
- (2016) NOBUHIKO NISHIJIMA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Twist mediates an aggressive phenotype in human colorectal cancer cells
- (2016) JUN-JIAN DENG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma
- (2016) Adrian Biddle et al. EBioMedicine
- ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2016) Takeshi Yoshida et al. PLoS One
- Existing drugs and their application in drug discovery targeting cancer stem cells
- (2015) Junfang Lv et al. ARCHIVES OF PHARMACAL RESEARCH
- miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells
- (2015) Z Zhao et al. CANCER GENE THERAPY
- FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition
- (2015) Zhijiao Zhou et al. CANCER LETTERS
- FOXF2 suppresses the FOXC2-mediated epithelial–mesenchymal transition and multidrug resistance of basal-like breast cancer
- (2015) Jun Cai et al. CANCER LETTERS
- Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
- (2015) M. Soucheray et al. CANCER RESEARCH
- Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
- (2015) Shusuke Toden et al. CARCINOGENESIS
- Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1αsignalling
- (2015) Bo Xu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer
- (2015) C. M. Della Corte et al. CLINICAL CANCER RESEARCH
- Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors
- (2015) Michael Juchum et al. DRUG RESISTANCE UPDATES
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptors
- (2015) LEI ZHAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells
- (2015) ZHENZHEN WEN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells
- (2015) Kesarin Busaranon et al. Journal of Natural Medicines
- Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells
- (2015) JINPENG LI et al. Molecular Medicine Reports
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity
- (2015) ADAM HERMAWAN et al. ONCOLOGY REPORTS
- Zerumbone attenuates TGF-β1-mediated epithelial–mesenchymal transition via upregulated E-cadherin expression and downregulated Smad2 signalling pathways in non-small cell lung cancer (A549) cells
- (2015) You-Cheng Hseu et al. Journal of Functional Foods
- Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
- (2015) T Namba et al. Cell Death & Disease
- Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment
- (2015) Jing Bai et al. Oncotarget
- MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
- (2015) Qingling Yang et al. Oncotarget
- Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation
- (2015) Yue Zhou et al. Oncotarget
- miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer
- (2015) Xiaohui Tan et al. Oncotarget
- MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2
- (2015) Hongzhan Liao et al. Oncotarget
- The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
- (2015) Rui Wang et al. Oncotarget
- Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
- (2015) Ge Qin et al. Oncotarget
- Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway
- (2015) Dan Han et al. Oncotarget
- Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
- (2015) Jia Ma et al. Oncotarget
- Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
- (2015) Rongrong Zhang et al. Stem Cell Research & Therapy
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- AMPK Reverses the Mesenchymal Phenotype of Cancer Cells by Targeting the Akt–MDM2–Foxo3a Signaling Axis
- (2014) Chih-Chien Chou et al. CANCER RESEARCH
- MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
- (2014) Li Jiang et al. FEBS LETTERS
- IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
- (2014) Matjaz Rokavec et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
- (2014) Jipeng Li et al. Molecular Cancer
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Animal Models and the Tumor Microenvironment: Studies of Tumor–Host Symbiosis
- (2014) Daniel Lindner SEMINARS IN ONCOLOGY
- Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
- (2014) Hua Sui et al. Oncology Research and Treatment
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
- (2013) Jian Guan et al. CANCER LETTERS
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo
- (2013) Mian Xie et al. EUROPEAN JOURNAL OF CANCER
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- Spatiotemporal Regulation of Epithelial-Mesenchymal Transition Is Essential for Squamous Cell Carcinoma Metastasis
- (2012) Jeff H. Tsai et al. CANCER CELL
- EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
- (2012) Thomas Brabletz CANCER CELL
- Screening therapeutic EMT blocking agents in a three-dimensional microenvironment
- (2012) Amir R. Aref et al. Integrative Biology
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- TGF- -induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion
- (2012) S. Lamouille et al. JOURNAL OF CELL SCIENCE
- Early events in cell adhesion and polarity during epithelial-mesenchymal transition
- (2012) R. Y.-J. Huang et al. JOURNAL OF CELL SCIENCE
- Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
- (2012) Y. Wu et al. MOLECULAR CANCER RESEARCH
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma
- (2012) Kian-Ngiap Chua et al. PLoS One
- Sonic Hedgehog Pathway Promotes Metastasis and Lymphangiogenesis via Activation of Akt, EMT, and MMP-9 Pathway in Gastric Cancer
- (2011) Y. A. Yoo et al. CANCER RESEARCH
- Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative
- (2011) A. Biddle et al. CANCER RESEARCH
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
- (2009) David J. McConkey et al. CANCER AND METASTASIS REVIEWS
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent and Selective Inhibitors of Breast Cancer Resistance Protein (ABCG2) Derived from thep-Glycoprotein (ABCB1) Modulator Tariquidar
- (2009) Matthias Kühnle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Companies Waver in Efforts To Target Transforming Growth Factor in Cancer
- (2009) K. Garber JNCI-Journal of the National Cancer Institute
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Metformin suppresses intestinal polyp growth in ApcMin/+ mice
- (2008) Ayako Tomimoto et al. CANCER SCIENCE
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- Cadherin switching
- (2008) M. J. Wheelock et al. JOURNAL OF CELL SCIENCE
- A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
- (2008) Jeffrey E. Lancet et al. LEUKEMIA RESEARCH
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started